Neuphoria Therapeutics (NEUP) Company Overview

Profile

Full Name:

Neuphoria Therapeutics Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 16, 2021

Indexes:

Not included

Description:

Neuphoria Therapeutics focuses on developing innovative treatments for mental health conditions using psychedelic compounds to improve patient outcomes and enhance well-being.

Events Calendar

Earnings

Next earnings date:

Nov 14, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Aug 25, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 24, 2024

Analyst ratings

Recent major analysts updates

Feb 4, 25 HC Wainwright & Co.
Buy

Screeners with NEUP included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Neuphoria Therapeutics?
  • Does Neuphoria Therapeutics pay dividends?
  • What sector is Neuphoria Therapeutics in?
  • What industry is Neuphoria Therapeutics in?
  • What country is Neuphoria Therapeutics based in?
  • When did Neuphoria Therapeutics go public?
  • Is Neuphoria Therapeutics in the S&P 500?
  • Is Neuphoria Therapeutics in the NASDAQ 100?
  • Is Neuphoria Therapeutics in the Dow Jones?
  • When was Neuphoria Therapeutics's last earnings report?
  • When does Neuphoria Therapeutics report earnings?
  • Should I buy Neuphoria Therapeutics stock now?

What is the ticker symbol for Neuphoria Therapeutics?

The ticker symbol for Neuphoria Therapeutics is NASDAQ:NEUP

Does Neuphoria Therapeutics pay dividends?

No, Neuphoria Therapeutics does not pay dividends

What sector is Neuphoria Therapeutics in?

Neuphoria Therapeutics is in the Healthcare sector

What industry is Neuphoria Therapeutics in?

Neuphoria Therapeutics is in the Biotechnology industry

What country is Neuphoria Therapeutics based in?

Neuphoria Therapeutics is headquartered in United States

When did Neuphoria Therapeutics go public?

Neuphoria Therapeutics's initial public offering (IPO) was on December 16, 2021

Is Neuphoria Therapeutics in the S&P 500?

No, Neuphoria Therapeutics is not included in the S&P 500 index

Is Neuphoria Therapeutics in the NASDAQ 100?

No, Neuphoria Therapeutics is not included in the NASDAQ 100 index

Is Neuphoria Therapeutics in the Dow Jones?

No, Neuphoria Therapeutics is not included in the Dow Jones index

When was Neuphoria Therapeutics's last earnings report?

Neuphoria Therapeutics's most recent earnings report was on Nov 14, 2024

When does Neuphoria Therapeutics report earnings?

The next expected earnings date for Neuphoria Therapeutics is Nov 14, 2025

Should I buy Neuphoria Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions